Login / Signup

Ibrutinib brain distribution: a preclinical study.

Lauriane GoldwirtKevin BeccariaAlain PleHélène SauvageonSamia Mourah
Published in: Cancer chemotherapy and pharmacology (2018)
The high level of ibrutinib brain distribution supports the clinical efficacy of this drug in CNS localization of MCL, CLL or PCNSL.
Keyphrases
  • chronic lymphocytic leukemia
  • resting state
  • white matter
  • functional connectivity
  • cerebral ischemia
  • blood brain barrier
  • cell therapy
  • multiple sclerosis
  • mesenchymal stem cells
  • brain injury
  • electronic health record